SRC and prostate carcinoma: Additionally, foreign studies have indicated that ER, located outside the nucleus, activates rapid‐response molecules like SRC and PI3K/AKT, thereby enhancing the tumorigenic potential of prostate cancer cells and increasing cell proliferation, migration, invasion, and tumor formation [13, 14, 15].